Amarna Therapeutics B.V.
Onglets principaux
À propos de votre organisation / profil
Amarna Therapeutics B.V. is a gene and immunotherapy company headquartered in Leiden The Netherlands. We have developed the Nimvec viral gene delivery vector platform that based on its unique non-immunogenic properties is ideally suited for developing safe and effective treatments for genetic disorders, inflammatory/degenerative/autoimmune diseases and allergies. With highly promising proof-of-principle results we are currently seeking for a Series A investment to conduct a clinical phase 1/2 study on our "first-in-class" Nimvec-based tolerization therapy for type 1 Diabetes Mellitus.
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.
Activités récentes
Amarna Therapeutics B.V. est désormais membre de la communauté EIC ACCESS+.
Amarna Therapeutics B.V. a publié une levée de fonds.
Peter de Haan a rejoint Amarna Therapeutics B.V..